Applied DNA Sciences Inc
APDN4.440USD
-0.130-2.84%
交易中 （美东）报价延迟15分钟
1.87M总市值
亏损市盈率 TTM
关于 Applied DNA Sciences Inc 公司
Applied DNA Sciences, Inc. 是一家生物技术公司。该公司致力于开发和商业化生产和检测脱氧核糖核酸 (DNA) 和核糖核酸 (RNA) 的技术。该公司通过三个部门运营：治疗性 DNA 生产服务、MDx 检测服务以及 DNA 标记和安全产品和服务。治疗性 DNA 生产服务部门的业务包括酶促制造合成 DNA 用于生产基于核酸的疗法，以及开发和销售专有 RNAP 用于生产信使 RNA (mRNA) 疗法。MDx 检测服务部门的业务包括执行和开发临床分子诊断和基因测试以及临床实验室检测服务。DNA 标记和安全产品和服务部门的业务包括为工业供应链和安全服务制造和检测 DNA。
公司简介
公司代码APDN
公司名称Applied DNA Sciences Inc
上市日期Aug 24, 2001
CEOMs. Judith Murrah
员工数量46
证券类型Ordinary Share
年结日Aug 24
公司地址50 Health Sciences Drive
城市STONY BROOK
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编11790
电话16312408800
网址https://adnas.com/
公司代码APDN
上市日期Aug 24, 2001
CEOMs. Judith Murrah
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President of LRx
President of LRx
4.00
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
3.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
3.00
--
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
2.00
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
2.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Dr. Sanford R. Simon, Ph.D.
Dr. Sanford R. Simon, Ph.D.
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President of LRx
President of LRx
4.00
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
3.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
3.00
--
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
2.00
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
2.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Product and authentication services - Large scale DNA production
333.66K
33.93%
Product and authentication services - Supply chain
290.23K
29.51%
Clinical laboratory testing services (over-time)
220.55K
22.43%
Research and development services
133.55K
13.58%
Product and authentication services - Asset marking
5.38K
0.55%
暂无数据
业务
地区
业务USD
名称
营收
占比
Product and authentication services - Large scale DNA production
333.66K
33.93%
Product and authentication services - Supply chain
290.23K
29.51%
Clinical laboratory testing services (over-time)
220.55K
22.43%
Research and development services
133.55K
13.58%
Product and authentication services - Asset marking
5.38K
0.55%
股东统计
更新时间: 7月19日 周六
更新时间: 7月19日 周六
持股股东
股东类型
持股股东
持股股东
占比
Sabby Management, LLC
1.34%
Altium Capital Management LP
1.25%
S.H.N. Financial Investments Ltd
0.97%
Bigger (Michael)
0.96%
Anson Funds Management LP.
0.88%
Other
94.60%
持股股东
持股股东
占比
Sabby Management, LLC
1.34%
Altium Capital Management LP
1.25%
S.H.N. Financial Investments Ltd
0.97%
Bigger (Michael)
0.96%
Anson Funds Management LP.
0.88%
Other
94.60%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
2.59%
Corporation
1.77%
Individual Investor
0.99%
Hedge Fund
0.89%
Investment Advisor
0.45%
Research Firm
0.03%
Other
93.28%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
62
34.90K
6.72%
-9.01K
2025Q1
84
45.20K
34.86%
+11.50K
2024Q4
79
25.60M
46.39%
+1.44M
2024Q3
74
1.08M
9.78%
+703.30K
2024Q2
73
1.19M
10.83%
+424.27K
2024Q1
67
243.32K
209.10%
+86.27K
2023Q4
64
96.98K
13.46%
-84.74K
2023Q3
66
149.12K
21.28%
-82.31K
2023Q2
68
142.47K
21.43%
-74.27K
2023Q1
68
128.77K
20.06%
-84.88K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Sabby Management, LLC
6.97K
1.34%
+1.29K
+22.64%
Dec 31, 2024
Altium Capital Management LP
6.50K
1.25%
--
--
Apr 03, 2025
S.H.N. Financial Investments Ltd
5.03K
0.97%
--
--
Apr 03, 2025
Bigger (Michael)
5.00K
0.96%
--
--
Apr 03, 2025
Anson Funds Management LP.
4.57K
0.88%
-9.44K
-67.39%
Apr 03, 2025
L1 Capital Global Opportunities Master Fund Ltd.
4.17K
0.8%
--
--
Apr 03, 2025
UBS Financial Services, Inc.
2.31K
0.44%
+2.31K
--
Mar 31, 2025
Grossman (Bruce)
111.00
0.02%
+111.00
--
Feb 02, 2024
Barclays Capital Inc.
80.00
0.02%
+80.00
--
Mar 31, 2025
SBI Securities Co., Ltd.
67.00
0.01%
-90.00
-57.32%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
公告日期
类型
比率
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
